By making advanced molecular parasite screening practical for routine wellness exams, KeyScreen provides veterinarians with a faster, more accurate path to positively impact the health of pets, people, and the broader community.Īt the heart of Antech is our love for pets and our desire to see them live longer, healthier lives.
#Antech diagnostics logo full
KeyScreen delivers a full report, along with other core diagnostic results, in just 24-48 hours, saving you time in clinic and providing a level of precision that's impossible to achieve with traditional O&P and ELISA methods. It can uniquely detect markers for anthelmintic drug-resistant hookworm and potentially zoonotic Giardia in addition to co-infections, all of which influence treatment selection, helping veterinarians uphold pharmacological stewardship and One Health principles. KeyScreen can detect 20 intestinal parasites from a single, storable 0.15 gram fecal sample. It uses molecular technology (PCR) to quickly detect and amplify small segments of nuclei acid from parasites' DNA or RNA, providing actionable insights that enable veterinarians to better care for pets, protect people and the environment, and practice antimicrobial stewardship to help preserve parasiticides. KeyScreen™ GI Parasite PCR is the most comprehensive GI parasite screening solution for cats and dogs. DNA doesn't lie, it's either there or it's not – there is no subjectivity."įind out more about KeyScreen here: About KeyScreen This innovation has important implications for GI parasite One Health and also, antimicrobial stewardship. KeyScreen is a significant advancement in veterinary diagnostics, providing a powerful tool to detect parasites in a way we have never been able to before. Leutenegger, Vice President of research and development at Antech and KeyScreen inventor who presented both abstracts at ACVIM Forum 2023 said: "Until recently, parasites have been adapting at a rate that has outpaced technology. And by doing so, veterinarians can provide the most efficient and effective care to protect the health of pets, their families and the broader community.ĭr. In practice, KeyScreen is part of veterinary day-to-day routine wellness, and in line with evidence and expert-based recommendations from CAPC/CPEP, which helps create the most accurate parasite profile possible for every pet. It is also highlighting One Health (the interconnection between human, animal and environmental health led by WHO, and in the US by the CDC) and pharmacological stewardship. KeyScreen is revolutionizing the field of routine veterinary parasite screening, by providing more detailed information on how parasites are adapting, emerging and spreading geographically. Because of Antech's agility, as of June 1, 2023, this second marker is now included in KeyScreen, providing additional practical – and the most advanced - information for veterinarians.
The existing drug resistance marker 167Y was found in 31 samples, while the marker 134H was found in an additional 8, thereby increasing the rate of resistant strains by 25%. 1 In addition, the problem of hookworm resistance is now emerging in Canada.
2 This new data shows that in North America, over 11% of detected canine hookworms were identified with the drug resistance marker 167Y. Research supports a growing body of KeyScreen dataĪnother KeyScreen study into anthelmintic-resistant canine hookworms in North America had found that the problem is much more widespread across the US. In addition to uncovering a much higher frequency of parasite infection, further research also shows the parasite problem to be more widespread in North America– both geographically and across dog breeds - than previously believed. Among the dog samples that identified hookworm, 1 in 10 (over 11%) were found to have the marker for anthelmintic drug (benzimidazole)-resistance. KeyScreen is the most advanced and comprehensive molecular diagnostic test, which can quickly detect 20 intestinal parasites in cats and dogs from a single 0.15 gram fecal sample, including markers for zoonotic Giardia and drug-resistant hookworm.Įvidence showed 1 in 4 dogs and cats (over 25%) were infected with at least one parasite, and co-infections (two or more parasites found in a single fecal sample) were detected in 1 in 5 pets with parasites (over 20%). As reported in the study 1, molecular diagnostic testing revealed over a quarter of dogs and cats from the studied population were infected with parasites (1 in 4), which shows much more sensitive detection than conventional fecal testing (1 in 10).
0 kommentar(er)
